Biodevelopment Corp.'s ORLAAM
Executive Summary
McLean, Virginia-based BDC holds the LAAM drug abuse treatment trademark, manufactures the bulk drug at its facility in Houston, was conferred the orphan drug designation for the product and is solely responsible for ORLAAM sales and marketing. The April 25 issue of "The Pink Sheet" (T&G-2) incorrectly identified the company